Back to Authors

Sitapara, Ravikumar

https://orcid.org/0000-0003-2366-6254

A5037554428 | I4210111220

Mayo Clinic

Gossamer Bio (United States)

Citations 3

Circulating biomarker results from a phase 2 study of seralutinib in pulmonary arterial hypertension

American Journal of Respiratory and Critical Care Medicine | May 7, 2026 | Volume: 212 | Issue: 8 | Pages: 1832-1837

10.1093/ajrccm/aamag175 | PMID 42104009

TORREY Phase 2 Study of Seralutinib in Pulmonary Arterial Hypertension (PAH): Circulating Biomarkers of Proliferation, Inflammation and Fibrosis Improve with Treatment

Pneumologie | March 18, 2025 | Volume: 79 | Issue: No issue available | Pages: No page available

10.1055/s-0045-1804783

TORREY Phase 2 Study of Seralutinib in Pulmonary Arterial Hypertension (PAH): Circulating Biomarkers of Proliferation, Inflammation, and Fibrosis Improve With Treatment

D105. BALBOA PARK EXPLORERS: TRANSLATIONAL SCIENCE AND EPIDEMIOLOGY IN PH | April 30, 2024 | Volume: No volume available | Issue: No issue available | Pages: A7383-A7383

10.1164/ajrccm-conference.2024.209.1_meetingabstracts.a7383